Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT03902951
What this trial is testing

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more
Jonsson Comprehensive Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT03570476
What this trial is testing

Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma Without Neuroendocrine DifferentiationStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+3 more
University of Washington 2